Health Canada: Hospira Healthcare Corporation Recalls Two Lots of …
Earthtimes (press release), UK
Any product from an affected lot should be returned to the pharmacy for replacement. Patients should not stop the use of Desferrioxamine Mesilate without consulting a health care practitioner. Patients should consult their physician or pharmacist if …